National Eye Institute launches data portal for macular degeneration research

The National Eye Institute (NEI) Data Commons now enables researchers to access data from patients with macular degeneration who participated in the Age-related Eye Disease Study 2 (AREDS2). The database complements newly available stem cell lines created by the New York Stem Cell Foundation Research Institute (NYSCF) from blood cells of AREDS2 study participants.

‘Expanse’ Supercomputer Formally Enters Production

The San Diego Supercomputer Center (SDSC) at UC San Diego announced that its new Expanse supercomputer formally entered service for researchers following a program review by the National Science Foundation (NSF), which awarded SDSC a grant in mid-2019 to build the innovative system.

Artificial Intelligence Algorithm Can Rapidly Detect Severity of Common Blinding Eye Disease

A new artificial intelligence (AI) algorithm developed by researchers at New York Eye and Ear Infirmary of Mount Sinai (NYEE) can rapidly and accurately detect age-related macular degeneration (AMD), a leading cause of vision loss in the United States.

Upgrades for LLNL supercomputer from AMD, Penguin Computing aid COVID-19 research

To assist in the COVID-19 research effort, Lawrence Livermore National Laboratory, Penguin Computing and AMD have reached an agreement to upgrade the Lab’s unclassified, Penguin Computing-built Corona high performance computing (HPC) cluster with an in-kind contribution of cutting-edge AMD Instinct™ accelerators, expected to nearly double the peak performance of the machine.

NEI researchers link age-related DNA modifications to susceptibility to eye disease

National Eye Institute (NEI) researchers profiling epigenomic changes in light-sensing mouse photoreceptors have a clearer picture of how age-related eye diseases may be linked to age-related changes in the regulation of gene expression. The findings, published online April 21 in Cell Reports, suggest that the epigenome could be targeted as a therapeutic strategy to prevent leading causes of vision loss, such as age-related macular degeneration (AMD).

Potential Way to Halt Blinding Macular Degeneration Identified

It would be the first treatment for “dry” age-related macular degeneration and could significantly improve treatment for wet AMD.

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2019 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

Christine Curcio, PhD, has been selected as the 2019 RPB David F. Weeks Award for Outstanding AMD Research (Weeks Award). The Weeks Award, funded through the generosity of Research to Prevent Blindness (RPB), an anonymous donor, and the Association of University Professors of Ophthalmology (AUPO), annually recognizes and celebrates an excellent researcher focused on age-related macular degeneration (AMD).